STOCK TITAN

[Form 4] Privia Health Group, Inc. Insider Trading Activity

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Privia Health Group, Inc. Chief Executive Officer Parth Mehrotra reported open-market sales of company common stock. He sold 105,439 shares on May 11 at a weighted average price of $22.55 per share and 15,647 shares on May 12 at a weighted average price of $22.64 per share, for total reported sales of 121,086 shares.

According to the footnotes, these sales were effected under a Rule 10b5-1 trading plan, and certain shares were sold on a nondiscretionary "sell to cover" basis to satisfy tax withholding on vested restricted stock units. After these transactions, Mehrotra directly holds 434,357 shares of Privia Health Group common stock. The filing notes that actual sale prices ranged from $22.28 to $23.10 per share.

Positive

  • None.

Negative

  • None.
Insider Mehrotra Parth
Role Chief Executive Officer
Sold 121,086 shs ($2.73M)
Type Security Shares Price Value
Sale Common Stock, $0.01 par value per share 15,647 $22.64 $354K
Sale Common Stock, $0.01 par value per share 105,439 $22.55 $2.38M
Holdings After Transaction: Common Stock, $0.01 par value per share — 434,357 shares (Direct, null)
Footnotes (1)
  1. Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
Shares sold May 11 105,439 shares Open-market sale at $22.55 weighted average price
Shares sold May 12 15,647 shares Open-market sale at $22.64 weighted average price
Total shares sold 121,086 shares Net reported sales across two trading days
Post-transaction holdings 434,357 shares CEO direct ownership after reported sales
Price range of sales $22.28–$23.10 per share Range of individual trade prices underlying weighted averages
May 11 weighted average price $22.55 per share Common stock, open-market sale
May 12 weighted average price $22.64 per share Common stock, open-market sale
Rule 10b5-1 trading plan regulatory
"sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
sell to cover financial
"sales represent a nondiscretionary sale of shares required to be sold ... pursuant to "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
restricted stock units financial
"tax withholding obligations in connection with the vesting and settlement of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mehrotra Parth

(Last)(First)(Middle)
PRIVIA HEALTH GROUP, INC.
950 N. GLEBE RD., SUITE 700

(Street)
ARLINGTON VIRGINIA 22203

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, $0.01 par value per share05/11/2026S(1)105,439D$22.55(2)450,004D
Common Stock, $0.01 par value per share05/12/2026S(3)15,647D$22.64434,357D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
Remarks:
/s/ Anita Beth Adams, as attorney-in-fact05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Privia Health Group (PRVA) report for its CEO?

Privia Health Group reported that CEO Parth Mehrotra sold 121,086 shares of common stock in open-market transactions. The sales occurred over two days at weighted average prices of $22.55 and $22.64 per share, as disclosed in the Form 4 filing.

Over what dates did the PRVA CEO sell shares and at what prices?

The CEO sold Privia Health (PRVA) shares on May 11 and May 12. He sold 105,439 shares at a weighted average price of $22.55 and 15,647 shares at $22.64, with individual trade prices ranging from $22.28 to $23.10.

How many Privia Health (PRVA) shares does the CEO hold after these sales?

After the reported transactions, CEO Parth Mehrotra directly holds 434,357 shares of Privia Health Group common stock. This post-transaction holding is stated in the Form 4 and reflects his remaining direct ownership following the two days of reported sales.

Were the PRVA CEO’s share sales under a Rule 10b5-1 trading plan?

Yes. The Form 4 footnotes state that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Such plans prearrange trades, making transaction timing more routine and less discretionary for the insider.

Did any of the Privia Health (PRVA) sales relate to tax withholding on RSUs?

Yes. The footnotes explain that certain sales represent a nondiscretionary "sell to cover" transaction. These shares were required to be sold to satisfy tax withholding obligations arising from the vesting and settlement of restricted stock units held by the CEO.

What price range did the PRVA CEO’s share sales occur within?

The Form 4 notes that the reported weighted average prices reflect multiple trades in a range from $22.28 to $23.10 per share. The CEO undertook to provide detailed trade-level pricing information upon request to investors or regulators.